BioNTech (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "BioNTech" in English language version.

refsWebsite

Global rank English rank

5reuters.com

49^th place

47^th place

5biontech.de

low place

4web.archive.org

1^st place

4doi.org

2^nd place

3faz.net

240^th place

1,443^rd place

2biontech.com

low place

2nih.gov

4^th place

2worldcat.org

5^th place

2fiercebiotech.com

low place

8,828^th place

2europa.eu

68^th place

117^th place

2eib.org

7,951^st place

4,722^nd place

2spiegel.de

66^th place

350^th place

2pharma-food.de

low place

1sec.gov

572^nd place

436^th place

1youtube.com

9^th place

13^th place

1sec.report

low place

1pharmavoice.com

low place

1nytimes.com

7^th place

1theguardian.com

12^th place

11^th place

1france24.com

481^st place

508^th place

1cato.org

4,789^th place

3,253^rd place

1ft.com

210^th place

157^th place

1capital.de

low place

1biontech-imfs.de

low place

1genomeweb.com

low place

1goethe-university-frankfurt.de

low place

1arstechnica.com

388^th place

265^th place

1forbes.hu

low place

1ump.edu.pl

low place

1harvard.edu

18^th place

17^th place

1semanticscholar.org

11^th place

8^th place

1aerzteblatt.de

3,043^rd place

low place

1gcs-web.com

6,526^th place

4,287^th place

1archive.today

14^th place

1marketwatch.com

1,303^rd place

808^th place

1nasdaq.com

2,740^th place

2,050^th place

1dw.com

204^th place

353^rd place

1globenewswire.com

2,614^th place

1,549^th place

1publishing.service.gov.uk

1,877^th place

1,129^th place

1gov.uk

432^nd place

278^th place

1fda.gov

447^th place

338^th place

1politico.eu

1,347^th place

909^th place

1pharmazeutische-zeitung.de

8,614^th place

low place

1wiwo.de

3,921^st place

low place

14investors.de

low place

1yahoo.com

38^th place

40^th place

1allgemeine-zeitung.de

low place

1deutsche-apotheker-zeitung.de

low place

1cnbc.com

220^th place

155^th place

1smh.com.au

132^nd place

96^th place

1swr.de

1,755^th place

8,499^th place

1rnd.de

2,679^th place

low place

1zdf.de

1,243^rd place

5,441^st place

1tagesschau.de

884^th place

4,117^th place

4investors.de

Michael Barck (21 December 2023). "BioNTech: FDA erteilt Breakthrough-Therapy-Status für Krebsmittel BNT323". 4Investors (in German). Retrieved 14 December 2024.

aerzteblatt.de

"Biontech sammelt Millionenbetrag ein". Deutsches Ärzteblatt. 10 July 2019. Retrieved 6 December 2019.

allgemeine-zeitung.de

"Bebauung der GFZ-Kaserne: Mehr Platz für Biontech?". Allgemeine Zeitung Mainz. 25 May 2020. Retrieved 12 November 2020.

archive.today

Sylke Maas; John Woolford; Jasmina Alatovic (16 August 2018). "BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza". BioNTech. Archived from the original on 8 December 2021. Retrieved 28 December 2022.

arstechnica.com

Beth Mole (2 October 2023). "After being demoted and forced to retire, mRNA researcher wins Nobel". Ars Technica. Retrieved 3 October 2023.

biontech-imfs.de

"Eufets Becomes BioNTech Innovative Manufacturing Services", BioNTech IMFS, 18 September 2017, retrieved 11 November 2020

biontech.com

"Locations". BioNTech. Retrieved 14 December 2024.
"Our Board Members". BioNTech. Retrieved 14 December 2024.

biontech.de

investors.biontech.de

"Prof. Christopher Huber". BioNTech. Retrieved 5 August 2021.
"SEC Filing | BioNTech". investors.biontech.de. p. 130. Retrieved 28 December 2020.
"BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs". BioNTech. 4 September 2019. Retrieved 27 December 2020.

biontech.de

"Aiming to address the global coronavirus pandemic: Project Lightspeed". BioNTech. 2020. Retrieved 13 December 2020.
"Locations". BioNTech. Retrieved 16 October 2022.

capital.de

Ben Stupples (2 March 2022). "Helmut Jeggle: vom Strüngmann-Vermögen zum eigenen Family Office". Capital. Retrieved 15 December 2024.

cato.org

Chris Edwards (24 September 2021). "The Triumph of Biotechnology and Private Capital". Cato Institute. Retrieved 15 December 2024.

cnbc.com

Saheli Roy Choudhury (20 May 2021). "BioNTech to produce vaccines in Singapore, its new regional headquarters". CNBC. Retrieved 14 December 2024.

deutsche-apotheker-zeitung.de

Thorsten Schüller (27 January 2023). "Biontech: Wegen Rahmenbedingungen ab nach England". Deutsche Apothekerzeitung. Retrieved 17 December 2023.

doi.org

Lena M. Kranz; Mustafa Diken; Heinrich Haas; Sebastian Kreiter; Carmen Loquai (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, 534 (7607): 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227, retrieved 11 November 2020
"EU forks out € 50 million to clean Internet". Network Security. 2004 (3): 3. March 2004. doi:10.1016/s1353-4858(04)00047-9. ISSN 1353-4858.
U. Sahin; E. Derhovanessian; M. Miller; B. P. Kloke; P. Simon; M. Löwer; V. Bukur; A. D. Tadmor; U. Luxemburger; B. Schrörs; T. Omokoko; M. Vormehr; C. Albrecht; A. Paruzynski; A. N. Kuhn; J. Buck; S. Heesch; K. H. Schreeb; F. Müller; I. Ortseifer; I. Vogler; E. Godehardt; S. Attig; R. Rae; A. Breitkreuz; C. Tolliver; M. Suchan; G. Martic; A. Hohberger; P. Sorn; J. Diekmann; J. Ciesla; O. Waksmann; A. K. Brück; M. Witt; M. Zillgen; A. Rothermel; B. Kasemann; D. Langer; S. Bolte; M. Diken; S. Kreiter; R. Nemecek; C. Gebhardt; S. Grabbe; C. Höller; J. Utikal; C. Huber; C. Loquai; Ö. Türeci (2017). "Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer". Nature. 547 (7662): 222–226. doi:10.1038/nature23003. PMID 28678784.

dx.doi.org

"EU forks out € 50 million to clean Internet". Network Security. 2004 (3): 3. March 2004. doi:10.1016/s1353-4858(04)00047-9. ISSN 1353-4858.

dw.com

Fabian Schmidt (22 April 2020). "Germany to start coronavirus vaccine trials". Deutsche Welle. Retrieved 15 December 2024.

eib.org

"BioNTech moves to head of pack for COVID-19 vaccine with EU finance". European Investment Bank. Retrieved 30 June 2021.
"BioNTech moves to head of pack for COVID-19 vaccine with EU finance". European Investment Bank. Retrieved 3 February 2021.

europa.eu

ec.europa.eu

"European Investment Bank provides funding of €50 million to BioNTech as part of the Investment Plan for Europe". European Commission. 17 December 2019. Retrieved 21 November 2020.
"Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing". European Commission. 11 June 2020. Retrieved 21 November 2020.

faz.net

"Biontech: An der Börse über 100 Milliarden Dollar wert". Frankfurter Allgemeine Zeitung (in German). 5 August 2021. Retrieved 2 September 2024.
Sebastian Balzter (27 January 2023). "Biontech auf Britisch". Frankfurter Allgemeine Zeitung (in German). Retrieved 14 December 2024.
Thorsten Winter (6 November 2018). "Krebs und Infektionen: Neuartige Impfstoffe als Ziel". Frankfurter Allgemeine Zeitung. Retrieved 14 December 2024.

fda.gov

Pfizer-BioNTech COVID-19 Vaccine Frequently Asked Questions, retrieved 22 December 2020

fiercebiotech.com

Nick Paul Taylor (21 September 2016). "Genentech lays $310M wager on BioNTech's mRNA cancer vaccine platform". FierceBiotech. Retrieved 7 December 2020.
Nick Paul Taylor (9 July 2019). "BioNTech raises $325M series B round to advance cancer pipeline". Fierce Biotech. Archived from the original on 28 December 2022. Retrieved 28 December 2022.

forbes.hu

"Magyar kutató, hányatatott sorsú szabadalma is kellett a most bejelentett vakcinához". forbes.hu (in Hungarian). 9 November 2020. Archived from the original on 26 January 2021. Retrieved 22 December 2020.

france24.com

"BioNTech's founders: scientist couple in global spotlight". France 24. 13 November 2020. Retrieved 22 December 2020.

ft.com

Joe Miller, Clive Cookson (16 December 2020). "FT People of the Year: BioNTech's Ugur Sahin and Ozlem Tureci". Financial Times. Retrieved 26 August 2024.

gcs-web.com

biontechse.gcs-web.com

Sylke Maas; John Woolford; Jasmina Alatovic (16 August 2018). "BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza". BioNTech. Archived from the original on 8 December 2021. Retrieved 28 December 2022.

genomeweb.com

"TheraCode to Acquire JPT Peptide Technologies". GenomeWeb. 11 May 2009. Retrieved 7 December 2020.

globenewswire.com

"BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162". GlobeNewswire News Room. 15 September 2020. Retrieved 3 February 2021.

goethe-university-frankfurt.de

"Prize Winners of the Paul Ehrlich and Ludwig Darmstaedter Prize 2022". Goethe University Frankfurt. 2022. Retrieved 15 December 2024.

gov.uk

"UK medicines regulator gives approval for first UK COVID-19 vaccine". Government of the United Kingdom. 2 December 2020. Retrieved 2 December 2020.

harvard.edu

ui.adsabs.harvard.edu

Lena M. Kranz; Mustafa Diken; Heinrich Haas; Sebastian Kreiter; Carmen Loquai (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, 534 (7607): 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227, retrieved 11 November 2020

marketwatch.com

Callum Keown, Lina Saigol (8 December 2020). "Here are 5 things to know about BioNTech and the married couple behind the COVID-19 vaccine developed with Pfizer". MarketWatch. Archived from the original on 29 December 2022. Retrieved 29 December 2022.

nasdaq.com

"BioNTech SE", NASDAQ, retrieved 12 November 2020

nih.gov

pubmed.ncbi.nlm.nih.gov

Lena M. Kranz; Mustafa Diken; Heinrich Haas; Sebastian Kreiter; Carmen Loquai (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, 534 (7607): 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227, retrieved 11 November 2020
U. Sahin; E. Derhovanessian; M. Miller; B. P. Kloke; P. Simon; M. Löwer; V. Bukur; A. D. Tadmor; U. Luxemburger; B. Schrörs; T. Omokoko; M. Vormehr; C. Albrecht; A. Paruzynski; A. N. Kuhn; J. Buck; S. Heesch; K. H. Schreeb; F. Müller; I. Ortseifer; I. Vogler; E. Godehardt; S. Attig; R. Rae; A. Breitkreuz; C. Tolliver; M. Suchan; G. Martic; A. Hohberger; P. Sorn; J. Diekmann; J. Ciesla; O. Waksmann; A. K. Brück; M. Witt; M. Zillgen; A. Rothermel; B. Kasemann; D. Langer; S. Bolte; M. Diken; S. Kreiter; R. Nemecek; C. Gebhardt; S. Grabbe; C. Höller; J. Utikal; C. Huber; C. Loquai; Ö. Türeci (2017). "Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer". Nature. 547 (7662): 222–226. doi:10.1038/nature23003. PMID 28678784.

nytimes.com

"Covid-19: Studies Indicate Pfizer-BioNTech Vaccine Protects Against the Most Severe Outcomes of Some Virus Variants". The New York Times. 5 May 2021. Retrieved 14 December 2024.

pharma-food.de

Ansgar Kretschmer (27 October 2021). "Biontech plant Impfstoff-Produktionsanlage in Afrika". Pharma + Food (in German). Retrieved 14 December 2024.
Nora Menzel (14 November 2022). "Biontech übernimmt GMP-Produktionsanlage in Singapur". Pharma + Food (in German). Retrieved 14 December 2024.

pharmavoice.com

Amy Baxter (14 August 2024). "Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope". PharmaVoice. Retrieved 15 December 2024.

pharmazeutische-zeitung.de

Christina Hohmann-Jeddi (22 June 2021). "mRNA-Vakzine: Biontech startet Phase-II-Studie mit Krebsimpfstoff". Pharmazeutische Zeitung (in German). Retrieved 14 December 2024.

politico.eu

"Commission approves BioNTech/Pfizer vaccine". Politico. 21 December 2020. Retrieved 22 December 2020.

publishing.service.gov.uk

assets.publishing.service.gov.uk

"Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine" (PDF). Government of the United Kingdom. 2 December 2020. Retrieved 2 December 2020.

reuters.com

Rebecca Spalding, Joshua Franklin (9 October 2019). "Germany's BioNTech raises $150 million in smaller-than-planned U.S. IPO amid market volatility". Reuters. Retrieved 7 December 2020.
Ludwig Burger (15 March 2020). "BioNTech in China alliance with Fosun over coronavirus vaccine candidate". Reuters. Retrieved 22 July 2021.
Ludwig Burger (29 June 2020). "Temasek-led investor group in $250 million vaccine bet on Germany's BioNTech". Reuters. Frankfurt. Retrieved 2 August 2020.
Ludwig Burger; Pratik Jain; Leroy Leo (10 January 2023). "Germany's BioNTech buys British AI startup InstaDeep". Reuters.
"BioNTech buys German site from Novartis to boost vaccine output". Reuters. 17 September 2020. Retrieved 14 December 2024.

rnd.de

"Moderna will seine erste Fabrik für Herstellung von mRNA-Impfstoffen in Afrika bauen". RedaktionsNetzwerk Deutschland. 8 March 2022. Retrieved 26 March 2022.

sec.gov

"BioNTech 2023 Annual Report (Form 20-F)". U.S. Securities and Exchange Commission. 20 March 2024. Retrieved 24 June 2023.

sec.report

BioNTech SE (9 September 2019), "Form F-1", U.S. Securities and Exchange Commission, archived from the original on 14 February 2021, retrieved 23 September 2020

semanticscholar.org

api.semanticscholar.org

Lena M. Kranz; Mustafa Diken; Heinrich Haas; Sebastian Kreiter; Carmen Loquai (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, 534 (7607): 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227, retrieved 11 November 2020

smh.com.au

Liam Mannix (7 October 2022). "mRNA giant wants changes to vaccine regulations to speed up new jabs". The Sydney Morning Herald (in German). Retrieved 14 December 2024.

spiegel.de

Thomas Schulz (4 February 2024). "Wie Biontech zum zweiten Mal Medizingeschichte schreiben will". Der Spiegel. Retrieved 14 December 2024.
"Biontech kauft Krebsspezialisten in den USA". Der Spiegel (in German). Retrieved 19 July 2021.

swr.de

"Biontech produziert Impfstoffe in RLP-Partnerland Ruanda". Südwestrundfunk (in German). 18 December 2023. Retrieved 14 December 2024.

tagesschau.de

"BioNTech will 2026 Krebsmedikament auf Markt bringen". Tagesschau (in German). 20 March 2020. Retrieved 26 November 2023.

theguardian.com

Hannah Devlin, Julia Kollewe (26 November 2021). "BioNTech says it could tweak Covid vaccine in 100 days if needed". The Guardian. Retrieved 14 December 2024.

ump.edu.pl

jmsnew.ump.edu.pl

Piotr Rzymski (7 December 2023). "The pivotal role of uridine modifications in the development of mRNA technology". Journal of Medical Sciences. Retrieved 15 December 2024.

web.archive.org

BioNTech SE (9 September 2019), "Form F-1", U.S. Securities and Exchange Commission, archived from the original on 14 February 2021, retrieved 23 September 2020
"Magyar kutató, hányatatott sorsú szabadalma is kellett a most bejelentett vakcinához". forbes.hu (in Hungarian). 9 November 2020. Archived from the original on 26 January 2021. Retrieved 22 December 2020.
Nick Paul Taylor (9 July 2019). "BioNTech raises $325M series B round to advance cancer pipeline". Fierce Biotech. Archived from the original on 28 December 2022. Retrieved 28 December 2022.
Callum Keown, Lina Saigol (8 December 2020). "Here are 5 things to know about BioNTech and the married couple behind the COVID-19 vaccine developed with Pfizer". MarketWatch. Archived from the original on 29 December 2022. Retrieved 29 December 2022.

wiwo.de

Jürgen Salz (12 April 2024). "Biontech: "Das würde ein neues Zeitalter in der Krebstherapie einleiten"". Wirtschaftswoche. Retrieved 14 December 2024.

worldcat.org

search.worldcat.org

Lena M. Kranz; Mustafa Diken; Heinrich Haas; Sebastian Kreiter; Carmen Loquai (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, 534 (7607): 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227, retrieved 11 November 2020
"EU forks out € 50 million to clean Internet". Network Security. 2004 (3): 3. March 2004. doi:10.1016/s1353-4858(04)00047-9. ISSN 1353-4858.

yahoo.com

finance.yahoo.com

"BioNTech Completes Acquisition of InstaDeep". Yahoo Finance (Press release). 31 July 2023. Retrieved 1 August 2023.

youtube.com

"BioNTech CEO on vaccine progress with Pfizer – YouTube". Retrieved 14 June 2021 – via YouTube.

zdf.de

"Krebs-Impfstoffe: Biontech plant Therapieansatz vor 2030". ZDFheute (in German). Retrieved 26 November 2023.